Active Development

Reset

Delivery Type

Reset

Duration Type

Reset

Developer

Reset

User

Reset

Hormonal

Reset

Development Stage

Reset

Potential MPT

Reset

API

Reset
Displaying 21 - 30 of 243
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: Peking University, Institute of Biomedical Engineering at Chinese Academy of Medical College
Project Stage: Pre-clinical
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: Shanghai Institute of Planned Parenthood Research (SIPPR)
Project Stage: Pre-clinical
Active Status: No
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: University of Washington
Project Stage: Pre-clinical
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: Murdoch University
Project Stage: Prototype Development
Alternative Name: BDADs
Active Status: No
User: Female, Male
Mode: No
Delivery Type: Oral
Developer: Focused Scientific, University of Washington
Project Stage: Pre-clinical
Alternative Name: Bromodomain Testis Associated, Cancer/Testis Antigen 9, Bromodomain Testis-Specific Protein, Bromodomain, Testis-Specific, RING3-Like Protein, CT9, SPGF21, BRD6
Target
User: Male
Mode: No
Delivery Type: Injectable, Oral
Role in reproduction: Spermatogenesis, Sperm Function
Project Stage: Lead Optimization
Active Status: Unknown
User: Male
Mode: No
Delivery Type: Oral
Developer: Bar-Ilan University
Role in reproduction: Sperm-Egg Interaction
Project Stage: Compound ID/Selection
Active Status: No
User: Female
Mode: No
Delivery Type: Vaginal Gel
Developer: ReProtect Inc.
Project Stage: Phase III
Alternative Name: Calcium Binding Tyrosine Phosphorylation Regulated, Cancer/Testis Antigen 88, Calcium-Binding Tyrosine Phosphorylation-Regulated Protein, Testis-Specific Calcium-Binding Protein CBP86, Calcium-Binding Protein 86, Fibrousheathin II, Fibrousheathin-2, CBP86, FSP-2, CT88, FSP2
Target
User: Female, Male
Mode: No
Role in reproduction: Spermatogenesis, Sperm Function
Project Stage: Target Validation
Alternative Name: Epididymal Calchlorin
Active Status: No
User: Male
Mode: No
Delivery Type: Injectable
Developer: Parsemus Foundation
Project Stage: Pre-clinical

Pages

CSV